AIX-EN-PROVENCE, France--(BUSINESS WIRE)--E-Scopics, the France-based medical ultrasound company and creator of a unique software-based liver assessment tool, welcomed the announcement that Madrigal ...

Surgical removal of parts of the liver remains the only curative approach for patients with liver-specific cancer. An international team led by Patrick Starlinger from MedUni Vienna has developed a ...

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--After successfully exhibiting its unique software-based liver assessment tool Hepatascope at the DDW Convention in San Diego and the EASL Conference in ...

Chronic liver disease (CLD) is responsible for significant morbidity and mortality. Most liver-related outcomes occur in people with advanced CLD, yet liver disease can be asymptomatic until the late ...

Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...

A new blood test can help the early identification of liver scarring in liver disease. Learn more about this study.

A substantial proportion of asymptomatic individuals in Greater Vancouver have undetected MASLD and significant fibrosis. Early identification of high-risk groups may support broader implementation of ...

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...

The prognosis of liver disease depends on the extent of fibrosis, which is usually staged with the use of liver biopsy. The limitations of biopsy have led to the development of noninvasive tests, ...